Welcome to Ypsomed

Spacer

Ypsomed is a worldwide leading independent developer and manufacturer of injection systems for custom-made self-administration and supplier of pen needles for the treatment of diabetes, growth disorders or infertility, as well as for further therapeutic areas. Ypsomed has well-established partnerships with numerous leading pharmaceutical and biotech companies such as Sanofi-Aventis, Eli Lilly, Pfizer, Roche, Genentech, Merck Serono, Amylin, NPS and others.

Ypsomed is headquartered in Burgdorf, Switzerland, and employs over 1200 employees at several production sites in Switzerland and throughout a European sales and distribution network.



© Copyright Ypsomed 2003- All rights reserved

News: 24th August 2010

Ypsomed streamlines executive management >>>more

News: 15th July 2010

mylife™ OmniPod® from Ypsomed >>>more

News: 14th June 2010

New web portal online at www.mylife-diabetescare.com >>>more

News: 25th May 2010

Media Conference May 25th 2010 >>>more

News: 25th May 2010

Ypsomed invests in new injection systems and diabetes care >>>more